Primary tabs
Export 83 results:
Filters: Author is Wim Van Molle
Hexacima: a fully liquid hexavalent vaccine (soon) on the market,
, Annual OMCL meeting, 13/6/2013, Issue EDQM, Helsinki, Finnland, (2013)
Possible presence of particles in MMR vaccines detected by Egyptian OMCL resolved by interaction with Belgian OMCL and manufacture,
, Annual OMCL Meeting, 11/6/2013, Issue EDQM, Helsinki, Finnland, (2013)
Quality control of polysaccharide vaccines by the Belgian National Control Lab (OMCL) in the European batch release framework: activity report 2012.,
, 0/10/2013, Brussels, Belgium, p.49, (2013)
Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation.,
, Modern Vaccines/adjuvants Formulation: Impact On Future Development, 17/5/2013, Issue Herriot,J., Vanden Bossche,G., Lausanne, Switserland, (2013)
Release testing by manufacturers & Ph.Eur. compliance: lessons learnt for competent authorities. A case study: the Extractable Volume,
, Annual OMCL meeting, 13/6/2012, Issue EDQM, NA, (2012)
Implementation over the past 20 years of the 3R's principle for batch release at the Scientific Institute of Public Health, Belgium (IPH).,
, Quality of medicines in a globalised world: dreams and reality, 15/10/2010, Issue European Directorate for the Quality of Medicines & HealthCare (EDQM),Council of Europe, Number 99, Prague, Czech Republic, p.98 - 99, (2010)
Testing and release of Synflorix ® monovalent conjugated bulks: update after 1 year of a complex vaccine with complex testing,
, Annual OMCL meeting, 2010, Issue EDQM, Split, Croatia, (2010)
Implementation of Synflorix® monovalent bulk testing,
, Annual OMCL meeting, 2009, Issue EDQM, Vienna, Austria, (2009)